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Abstract
Study Design: Retrospective cohort study.
Objective: Malnutrition has been shown to be a risk factor for poor perioperative outcomes in multiple surgical subspecialties,
but few studies have specifically investigated the effect of hypoalbuminemia in patients undergoing operative treatment of
metastatic spinal tumors. The aim of this study was to assess the role of hypoalbuminemia as an independent risk factor for 30-day
perioperative mortality and morbidity after surgical decompression of metastatic spinal tumors using the American College of
Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database from 2011 to 2014.
Methods: We identified 1498 adult patients in the ACS-NSQIP database who underwent laminectomy and excision of metastatic
extradural spinal tumors. Patients were categorized into normoalbuminemic and hypoalbuminemic (ie, albumin level <3.5 g/dL)
groups. Univariate and multivariate regression analyses were performed to examine the association between preoperative
hypoalbuminemia and 30-day perioperative mortality and morbidity. Subgroup analysis was performed in the hypoalbuminemic
group to assess the dose-dependent effect of albumin depletion.
Results: Hypoalbuminemia was associated with increased risk of perioperative mortality, any complication, sepsis, intra- or
postoperative transfusion, prolonged hospitalization, and non-home discharge. However, albumin depletion was also associated
with decreased risk of readmission. There was an albumin level–dependent effect of increasing mortality and complication rates
with worsening albumin depletion.
Conclusions: Hypoalbuminemia is an independent risk factor for perioperative mortality and morbidity following surgical
decompression of metastatic spinal tumors with a dose-dependent effect on mortality and complication rates. Therefore, it is
important to address malnutrition and optimize nutritional status prior to surgery.
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Introduction
In the United States, approximately 1.66 million new cases of
cancer are diagnosed each year. Up to 84% of cancer patients
develop bony metastasis, with the most common site of
metastasis being the spine.1-5 Spinal metastases develop in
approximately 18 000 patients in North America each year.5-7
Surgical treatment of metastatic spinal tumors is often pallia-
tive, with the goal of decompressing neural structures,
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alleviating pain, preventing deformity, and encouraging
patient mobilization.3,8-12 However, operative treatment of
spinal tumors often involves extensive procedures with high
rates of perioperative complications that can significantly
increase health care costs.1,2,13 In addition, cancer patients
who develop spinal metastasis tend to be a frail cohort with
multiple medical comorbidities and poor functional status that
are independently associated with high complication rates and
health care resource utilization as well.4,9,14-16
The role of malnutrition in perioperative complications
following orthopedic surgery has received increasing atten-
tion in recent literature.17-21 Malnutrition is common in can-
cer patients, especially in patients with late-stage cancer who
are suffering from cachexia.22 The pathophysiology of mal-
nutrition in cancer patients is complex, involving host-tumor
interactions, anticancer therapies, inflammatory cytokines,
increased energy requirements, and caloric losses despite nor-
mal food intake.23-25
Serum albumin level is a recognized parameter of assessing
nutritional status, as well as disease severity and progression
in cancer patients.26 Hypoalbuminemia has been extensively
studied as a prognostic indicator for poor surgical outcomes
after spinal surgery,21,26-30 but few studies have examined
hypoalbuminemia alone as an independent risk factor for peri-
operative complications following surgical decompression of
spinal tumors.31 In this study, we aim to assess the impact of
hypoalbuminemia on 30-day perioperative mortality and mor-
bidity in patients undergoing laminectomy for excision of




This was a retrospective analysis of prospectively collected
data from 2011 to 2014 in the American College of Surgeons
National Surgical Quality Improvement Program (ACS-
NSQIP) database.32 The ACS-NSQIP is a national database
of 30-day postoperative morbidity and mortality outcomes
from more than 500 institutions in the United States. The
database includes more than 300 variables on patient demo-
graphic, preoperative, intraoperative, and early postoperative
variables.32
Cohort Selection
A total of 1498 adult patients aged 18 years or older undergoing
laminectomy and excision of metastatic extradural spinal
tumors were identified and included in our cohort. Patients with
intradural spinal tumors or primary tumors of the spine were
excluded. Primary spinal tumors tend to be intradural and
benign in nature, therefore constituting a different patient
cohort at baseline than patients with spinal metastases. Cases
missing preoperative albumin levels were excluded.
Baseline Patient Characteristics
Baseline patient characteristics included patient demographics,
medical comorbidities, preoperative condition, and operative
variables. Patient demographics included sex, race, and age.
Medical comorbidities included a history of obesity (body mass
index 30 kg/m2), diabetes, smoking within 1 year of surgery,
a history of chronic obstructive pulmonary disease or ventilator
dependence within 48 hours prior to surgery, use of hyperten-
sive medication within 30 days prior to surgery or a history of
chronic heart failure, dialysis within 2 weeks prior to surgery or
acute renal failure within 24 hours prior to surgery, acute or
chronic bleeding disorder, and chronic steroid use within
30 days prior to surgery. Preoperative condition was indicated
by variables including American Society of Anesthesiologists
(ASA) classification 3, presence of dyspnea at rest within 30
days prior to surgery, functional status (independent, partial, or
total dependence), a history of10% unintentional weight loss
during the 6 months prior to surgery, anemia (hematocrit <40%
in males and <36% in females), preoperative transfusion of 1
unit of packed red blood cells or whole blood within 72 hours
prior to surgery, and thrombocytopenia (platelets <150 000).
Operative variables included whether the procedure was urgent
or emergent, and whether a concurrent fusion was performed
with the decompression. The variable of interest was the pre-
operative serum albumin level. Hypoalbuminemia was defined
as a serum albumin level <3.5 g/dL.
Thirty-Day Perioperative Outcomes
Primary outcome measures in this study were mortality and
other perioperative complications occurring within 30 days fol-
lowing surgery. Complications included reoperation, operative
site complications (deep surgical site infection, organ space
infection, or wound dehiscence), cardiac complications (cardiac
arrest requiring cardiopulmonary resuscitation or myocardial
infarction), pulmonary complications (pneumonia, postoperative
reintubation, or failure to wean from a ventilator after 48 hours),
renal complications (progressive renal insufficiency or acute
renal failure), venous thromboembolism (pulmonary embolism
or deep vein thrombosis), sepsis, urinary tract infection (UTI),
intra- or postoperative transfusion of packed red blood cells or
whole blood, prolonged length of stay (LOS) 10 days, non-
home discharge, and unplanned readmission.
Statistical Analysis
Univariate analysis was performed on patient demographics
and baseline characteristics using Pearson’s w2 test. Fischer’s
exact test was used when appropriate. Multivariate (MVR)
regression models were performed while adjusting for patient
demographics and baseline characteristics in order to identify
the effect of hypoalbuminemia on 30-day perioperative mor-
tality and morbidity. Demographic, medical comorbidity, and
operative variables that were statistically different between
study groups were included as covariates in the MVR
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regression analysis. Subgroup analysis was performed in the
hypoalbuminemic group by stratifying patients into approxi-
mate quartiles based on preoperative albumin levels. Univari-
ate and MVR regression analyses were performed to identify
the effect of worsening albumin depletion on 30-day periopera-
tive mortality and morbidity. Odds ratios (ORs) and 95% con-
fidence intervals (CIs) were reported. Statistical significance
was set at P ¼ .05. All statistical analysis was performed using
SAS Studio Version 3.4 (SAS Institute Inc, Cary, NC).
Results
Patient Baseline Characteristics
In our cohort of 1498 patients, the mean preoperative albumin
level was 3.66 g/dL with a standard deviation of 0.66 g/dL
(Figure 1). Hypoalbuminemia was present in 34.2%
(512/1498) of patients. Baseline patient characteristics were
significantly different between the normoalbuminemic and
hypoalbuminemic groups (Table 1). There were significant
Figure 1. Preoperative serum albumin levels of 1498 patients. The
red line represents the cutoff for hypoalbuminemia (ie, albumin
3.5 g/dL). The mean albumin level was 3.66 g/dL with a standard
deviation of 0.66 g/dL. Hypoalbuminemia was present in 34.2% (512/
1498) of patients.
Table 1. Baseline Patient Characteristics in the Normoalbuminemic and Hypoalbuminemic Groups, Including Medical Comorbidities at the
Time of Surgery, Preoperative Condition, and Operative Variables.
Normoalbuminemia (n ¼ 986) Hypoalbuminemia (n ¼ 512)
n % n % P
Sex
Male 644 65.3 328 64.1 .376
Female 340 34.5 184 35.9
Race
White 756 77.8 392 77.5 .177
Black 90 9.3 62 12.3
Other 46 4.7 18 3.6
Unknown 80 8.2 34 6.7
Age 65 400 40.6 186 36.3 .110
Medical comorbidities
Obesity 302 30.6 138 27.0 .137
Diabetes 120 12.2 86 16.8 .010
Smoking 168 17.0 122 23.8 .002
Pulmonarya 38 3.9 46 9.0 <.001
Cardiacb 482 48.9 234 45.7 .242
Renalc 2 0.2 6 1.2 .018
Bleeding disorder 36 3.7 48 9.4 <.001
Chronic steroid use 102 10.3 88 17.2 <.001
Preoperative condition
ASA class 3 774 78.5 476 93.0 <.001
Dyspnea at rest 72 7.3 78 15.2 <.001
Poor functional statusd 76 7.7 108 21.1 <.001
Weight loss 50 5.1 84 16.4 <.001
Anemia 442 44.8 394 77.0 <.001
Preoperative transfusion 24 2.4 40 7.8 <.001
Platelets <150 000 82 8.3 114 22.3 <.001
Operative variables
Nonelective surgery 398 43.9 352 74.0 <.001
Concurrent fusion 510 51.7 268 52.3 .829
Abbreviation: ASA, American Society of Anesthesiologists.
aPulmonary comorbidity was defined as a history of chronic obstructive pulmonary disease or ventilator dependence within 48 hours prior to surgery.
bCardiac comorbidity was defined as the use of hypertensive medication or a history of chronic heart failure.
cRenal comorbidity was defined as dialysis treatment within 2 weeks prior to surgery or acute renal failure within 24 hours prior to surgery.
dPoor functional status was defined as partial or total dependence.
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differences in medical comorbidities, including diabetes
(P ¼ .010), smoking (P ¼ .002), pulmonary comorbidity
(P < .001), renal comorbidity (P ¼ .018), bleeding disorder
(P < .001), and chronic steroid use (P < .001). There were signif-
icant differences in preoperative patient condition, including
ASA classification (P < .001), dyspnea at rest (P < .001), func-
tional status (P < .001), unintentional weight loss (P < .001),
anemia (P < .001), preoperative transfusion (P < .001), and throm-
bocytopenia (P < .001). The proportion of urgent or emergent
surgeries was also significantly different between the 2 groups
(P < .001).
Univariate Analysis
Results of the univariate analysis are summarized in Table 2.
There was a statistically significant difference in 30-day mor-
tality between the 2 groups, with a rate of 3.3% in the normoal-
buminemic group and 17.2% in the hypoalbuminemic group
(P < .001). There were also significant differences in perio-
perative complications. Hypoalbuminemic patients had a
higher rate of any perioperative complication (hypoalbumine-
mic, 77.3%; normoalbuminemic, 48.1%; P < .001). Specifi-
cally, hypoalbuminemic patients had higher rates of
pulmonary complications (P ¼ .025), venous thromboembo-
lism (P ¼ .023), sepsis (P < .001), perioperative transfusion
(P < .001), prolonged LOS (P < .001), and non-home discharge
(P < .001). There were no significant differences in reopera-
tion, surgical site complications, cardiac complications, renal
complications, UTI, and unplanned readmission.
Multivariate Regression Analysis
Results of the MVR regression analysis are summarized in
Figure 2 and Table 3. Hypoalbuminemic patients had a higher
risk of perioperative mortality (adjusted OR¼ 5.20; CI¼ 3.36-
8.04; P < .001), any complication (adjusted OR ¼ 3.16;
CI ¼ 2.44-4.10; P < .001), sepsis (adjusted OR ¼ 3.05; CI ¼
1.88-4.92; P < .001), intra- or postoperative transfusion
(adjusted OR ¼ 1.43; CI ¼ 1.11-1.83; P ¼ .005), prolonged
LOS (adjusted OR ¼ 4.32; CI ¼ 3.31-5.63; P < .001), and
Table 2. Univariate Analysis of 30-Day Perioperative Mortality and Morbidity in Normoalbuminemic and Hypoalbuminemic Patients.
Normoalbuminemia (n ¼ 986) Hypoalbuminemia (n ¼ 512)
n % n % P
Mortality 32 3.3 88 17.2 <.001
Any complication 474 48.1 396 77.3 <.001
Reoperation 48 5.3 34 7.2 .167
Wound complications 26 2.6 16 3.1 .590
Cardiac complications 10 1.0 4 0.8 .652
Pulmonary complications 36 3.7 32 6.3 .025
Renal complications 4 0.4 4 0.8 .357
Venous thromboembolism 54 5.5 44 8.6 .023
Sepsis 30 3.0 44 8.6 <.001
Urinary tract infection 26 2.6 18 3.5 .346
Intra- or postoperative transfusion 294 29.8 220 43.0 <.001
Prolonged length of stay 10 days 140 14.2 226 44.1 <.001
Non-home discharge 308 33.8 288 60.5 <.001
Readmissiona 24 16.9 10 11.1 .217
aUnplanned 30-day readmission data was only available for the period from 2012 to 2014 (n ¼ 232).
Figure 2. Multivariate regression analysis of perioperative mortality
and complications that were significantly associated with hypoalbu-
minemia. Adjusted odds ratios are illustrated with 95% confidence
intervals. LOS, length of stay.
Table 3. Multivariate Regression Analysis of the Effect of
Hypoalbuminemia on Perioperative Mortality and Morbidity Using
Normoalbuminemic Patients as the Reference Groupa.
Adjusted OR (95% CI) P
Mortality 5.20 (3.36-8.04) <.001
Any complication 3.16 (2.44-4.10) <.001
Sepsis 3.05 (1.88-4.92) <.001
Intra- or postoperative transfusion 1.43 (1.11-1.83) .005
Prolonged LOS 4.32 (3.31-5.63) <.001
Non-home discharge 2.92 (2.28-3.73) <.001
Readmission 0.18 (0.05-0.63) .007
Abbreviations: OR, odds ratio; CI, confidence interval; LOS, length of stay.
aOdds ratios and 95% confidence intervals are reported for perioperative
mortality and complications that were significantly associated with
hypoalbuminemia.
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non-home discharge (adjusted OR ¼ 2.92; CI ¼ 2.28-3.73;
P < .001). In contrast, the risk of unplanned readmission was
lower in patients with hypoalbuminemia (adjusted OR ¼ 0.18;
CI ¼ 0.05-0.63; P ¼ .007).
Subgroup Analysis
Patients in the hypoalbuminemic group (n ¼ 512) were strati-
fied into approximately quartiles based on preoperative albu-
min levels. The mild hypoalbuminemia group consisted of 126
patients with serum albumin levels of 3.3 to 3.4 g/dL. The mild-
moderate hypoalbuminemia group included 124 patients with
serum albumin levels of 3.1 to 3.2 g/dL. The moderate-severe
hypoalbuminemia group consisted of 96 patients with serum
albumin levels of 2.8 to 3.0 g/dL. The severe hypoalbuminemia
group consisted of 166 patients with serum albumin levels of
1.2 to 2.7 g/dL. There were significant differences in race (P ¼
.038), pulmonary comorbidity (P ¼ .049), renal comorbidity
(P ¼ .003), ASA classification (P < .001), preoperative func-
tional status (P ¼ .020), unintentional weight loss (P < .001),
preoperative anemia (P < .001), and nonelective surgery (P <
.001) among the subgroups (Table 4).
Results of the univariate subgroup analysis are shown in
Table 5. There was a consistent relationship between worsen-
ing hypoalbuminemia and higher rates of perioperative mortal-
ity (mild, 6.4%; mild-moderate, 16.1%; moderate-severe,
18.8%; severe, 25.3%; P < .001) and any complication (mild,
65.9%; mild-moderate, 71.0%; moderate-severe, 79.2%;
severe, 89.8%; P < .001). In particular, patients with more
severe albumin depletion had higher rates of pulmonary com-
plications (mild, 3.2%; mild-moderate, 3.2; moderate-severe,
8.3%; severe, 9.6%; P ¼ .041) and prolonged LOS (mild,
30.2%; mild-moderate, 41.9%; moderate-severe, 43.8%;
severe, 56.5%; P < .001). There were also significant differ-
ences in the rates of venous thromboembolism (P ¼ .037),
sepsis (P ¼ .036), UTI (P ¼ .025), and non-home discharge
Table 4. Baseline Patient Characteristics Among the 4 Subgroupsa.
Mild (n ¼ 126),
n (%)
Mild-Moderate
(n ¼ 124), n (%)
Moderate-Severe
(n ¼ 96), n (%)
Severe (n ¼ 166),
n (%) P
Sex
Male 84 (66.7%) 76 (61.3%) 68 (70.8%) 100 (60.2%) .284
Female 42 (33.3%) 48 (38.7%) 28 (29.2%) 66 (39.8%)
Race
White 104 (83.9%) 96 (80.0%) 70 (72.9%) 122 (73.5%) .038
Black 10 (8.1%) 14 (11.7%) 18 (18.8%) 20 (12.1%)
Other 2 (1.6%) 2 (1.7%) 6 (6.3%) 8 (4.8%)
Unknown 8 (6.5%) 8 (6.7%) 2 (2.1%) 16 (9.6%)
Age 65 42 (33.3%) 44 (35.5%) 42 (43.8%) 58 (34.9%) .407
Medical comorbidities
Obesity 38 (30.2%) 28 (22.6%) 34 (35.4%) 38 (22.9%) .085
Diabetes 20 (15.9%) 16 (12.9%) 16 (20.5%) 34 (20.5%) .384
Smoking 24 (19.1%) 30 (24.2%) 26 (27.1%) 42 (25.3%) .490
Pulmonaryb 8 (6.4%) 12 (9.7%) 4 (4.2%) 22 (13.3%) .049
Cardiacc 68 (54.0%) 52 (41.9%) 42 (43.8%) 72 (43.4%) .197
Renald 0 (0.0%) 0 (0.0%) 0 (0.0%) 6 (3.6%) 0.003
Bleeding disorder 8 (6.4%) 10 (8.1%) 8 (8.3%) 22 (13.3%) .209
Chronic steroid use 24 (19.1%) 12 (9.7%) 18 (18.8%) 34 (20.5%) .062
Preoperative condition
ASA class 3 108 (85.7%) 112 (90.3%) 94 (97.9%) 162 (97.6%) <.001
Dyspnea at rest 22 (17.5%) 20 (16.1%) 12 (12.5%) 24 (14.5%) .752
Poor functional statuse 16 (12.7%) 24 (19.4%) 24 (25.0%) 44 (26.5%) .020
Weight loss 10 (7.9%) 14 (11.3%) 20 (20.8%) 40 (24.1%) <.001
Anemia 92 (73.0%) 68 (54.8%) 84 (87.5%) 150 (90.4%) <.001
Preoperative transfusion 4 (3.2%) 10 (8.1%) 6 (6.3%) 20 (12.1%) .033
Platelets <150 000 24 (19.1%) 22 (17.7%) 22 (22.9%) 46 (27.7%) .168
Operative variables
Nonelective surgery 80 (67.8%) 70 (61.4%) 72 (80.0%) 130 (84.4%) <.001
Concurrent fusion 76 (60.3%) 72 (58.1%) 46 (47.9%) 74 (44.6%) .022
Abbreviation: ASA, American Society of Anesthesiologists.
aMild, mild-moderate, moderate-severe, and severe hypoalbuminemia were defined as a serum albumin level of 3.3 to 3.4 g/dL, 3.1 to 3.2 g/dL, 2.8 to 3.0 g/dL, and
1.2 to 2.7 g/dL, respectively.
bPulmonary comorbidity was defined as a history of chronic obstructive pulmonary disease or ventilator dependence within 48 hours prior to surgery.
cCardiac comorbidity was defined as the use of hypertensive medication or a history of chronic heart failure.
dRenal comorbidity was defined as dialysis treatment within 2 weeks prior to surgery or acute renal failure within 24 hours prior to surgery.
ePoor functional status was defined as partial or total dependence.
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(P¼ .026) among the subgroups, but without a consistent trend
in the relationship between the severity of albumin depletion
and complication rates. There were no significant differences
among the subgroups in terms of reoperation, surgical site
complications, cardiac complications, renal complications,
perioperative transfusion, and unplanned readmission.
On MVR analysis, patients with mild hypoalbuminemia
were used as the reference group. Worsening hypoalbumine-
mia was consistently associated with increased risk of mortality
and any complication (Table 6, Figure 3). Patients with severe
hypoalbuminemia had significantly higher risk of prolonged
LOS than patients with mild hypoalbuminemia (adjusted
OR ¼ 2.52; CI ¼ 1.46-4.33; P < .001). Patients with mild-
moderate hypoalbuminemia had significantly higher risk of
venous thromboembolism than patients with mild hypoalbumi-
nemia (adjusted OR¼ 3.03; CI¼ 1.17-7.89; P¼ .023). However,
patients with moderate-severe and severe hypoalbuminemia did
not have a significantly different risk of venous thromboembo-
lism than patients with mild hypoalbuminemia.
Discussion
Malnutrition is common in the cancer patient population and
has been associated with higher rates of complications in
patients with metastatic spinal disease.27,29-31 In this retrospec-
tive study of 1498 patients in the ACS-NSQIP database who
underwent surgical decompression for metastatic extradural
spinal tumors, we demonstrated that hypoalbuminemia is an
independent risk factor for 30-day perioperative mortality and
morbidity. Albumin levels below 3.5 g/dL were associated with
increased risk of perioperative mortality, any complication,
sepsis, intra- or postoperative transfusion, prolonged hospitali-
zation, and non-home discharge. These findings support serum
albumin level as a valuable prognostic measure for poor surgi-
cal outcomes in patients with metastatic spinal tumors.
Hypoalbuminemia was associated with a 5-fold increase in
the risk of 30-day mortality, and our subgroup analysis
demonstrated that there was an albumin level–dependent
association between the severity of albumin depletion and
mortality rate. The perioperative mortality rate in our hypoal-
buminemic group was 17.2%, which is higher than previously
reported rates of 3% to 13%.9,13,20,33-35 Hypoalbuminemic
patients also experienced a 3-fold increased risk of any peri-
operative complication compared with normoalbuminemic
Table 5. Univariate Analysis of 30-Day Perioperative Mortality and Morbidity in Patients With Varying Severities of Hypoalbuminemiaa.
Mild, n (%) Mild-Moderate, n (%) Moderate-Severe, n (%) Severe, n (%) P
Mortality 8 (6.4%) 20 (16.1%) 18 (18.8%) 42 (25.3%) <.001
Any complication 83 (65.9%) 88 (71.0%) 76 (79.2%) 149 (89.8%) <.001
Reoperation 14 (12.1%) 6 (5.2%) 4 (4.4%) 10 (6.6%) .138
Wound complications 8 (6.4%) 2 (1.6%) 2 (2.1%) 4 (2.4%) .159
Cardiac complications 0 (0.0%) 2 (1.6%) 2 (2.1%) 0 (0.0%) .076
Pulmonary complications 4 (3.2%) 4 (3.2%) 8 (8.3%) 16 (9.6%) .041
Renal complications 2 (1.6%) 0 (0.0%) 2 (2.1%) 0 (0.0%) .079
Venous thromboembolism 8 (6.4%) 18 (14.5%) 4 (4.2%) 14 (8.4%) .037
Sepsis 10 (7.9%) 4 (3.2%) 12 (12.5%) 18 (10.8%) .036
Urinary tract infection 8 (6.4%) 4 (3.2%) 0 (0.0%) 6 (3.6%) .025
Intra- or postoperative transfusion 48 (38.1%) 52 (41.9%) 46 (47.9%) 74 (44.6%) .491
Prolonged length of stay 10 days 38 (30.2%) 52 (41.9%) 42 (43.8%) 94 (56.5%) <.001
Non-home discharge 66 (55.9%) 62 (52.5%) 56 (62.2%) 104 (69.3%) .026
Readmissionb 2 (14.3%) 2 (9.1%) 2 (11.1%) 4 (11.1%) .973
aMild, mild-moderate, moderate-severe, and severe hypoalbuminemia were defined as a serum albumin level of 3.3 to 3.4 g/dL, 3.1 to 3.2 g/dL, 2.8 to 3.0 g/dL, and
1.2 to 2.7 g/dL, respectively.
bUnplanned 30-day readmission data was only available for the period from 2012 to 2014 (n ¼ 232).
Table 6. Multivariate Regression Analysis of the Effect of Varying
Severities of Hypoalbuminemia on 30-Day Perioperative Mortality
and Morbidity Using Mild Hypoalbuminemia (ie, Serum Albumin
Level of 3.3-3.4 g/dL) as Referencea.
Adjusted OR (95% CI) P
Mortality
Mild-moderate 3.03 (1.25-7.36) .014
Moderate-severe 3.11 (1.26-7.67) .014
Severe 4.48 (1.97-10.16) <.001
Any complication
Mild-moderate 1.06 (0.58-1.91) .859
Moderate-severe 2.23 (1.13-4.42) .022
Severe 5.30 (2.66-10.58) <.001
Venous thromboembolism
Mild-moderate 3.03 (1.17-7.89) .023
Moderate-severe 0.56 (0.15-2.07) .388
Severe 1.74 (0.65-4.67) .272
Prolonged LOS
Mild-moderate 1.31 (0.74-2.31) .359
Moderate-severe 1.36 (0.73-2.51) .334
Severe 2.52 (1.46-4.33) <.001
Abbreviations: OR, odds ratio; CI, confidence interval; LOS, length of stay.
aOdds ratios and 95% confidence intervals are reported for perioperative
mortality and complications that were significantly associated with the severity
of hypoalbuminemia. Mild-moderate, moderate-severe, and severe hypoalbu-
minemia were defined as a serum albumin level of 3.1 to 3.2 g/dL, 2.8 to 3.0 g/dL,
and 1.2 to 2.7 g/dL, respectively.
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patients, with an albumin level–dependent relationship
between worsening albumin depletion and complication rate.
The rate of any complication in hypoalbuminemic patients
was 77.3%, which is slightly higher than previously reported
rates of 10% to 76%.1,15,30,36-40 These results are consistent
with malnutrition being a risk factor for poor early postopera-
tive outcomes.
Patients with hypoalbuminemia had a 1.4 times increased
risk of intra- or postoperative transfusion. The incidence of
perioperative blood loss requiring transfusion was 43.0% in the
hypoalbuminemic group. Mean blood loss after surgical
decompression of spinal tumors ranges from 500 to 2300 mL
and these procedures are associated with high transfusion
rates.1,20,41-43 Minimizing blood loss and perioperative transfu-
sions not only reduces health care costs14,15,44,45 but may also
play a role in reducing perioperative mortality.46-50 Periopera-
tive transfusion of allogeneic blood has also been associated
with higher infection rates following various orthopedic proce-
dures,48,51-55 and in this study, 48.6% of patients with perio-
perative sepsis had received a perioperative blood transfusion.
Therefore, our results support optimization of albumin levels
preoperatively in order to minimize perioperative transfusions
and their associated complications.
Hypoalbuminemia was associated with an increased risk of
perioperative sepsis. The incidence of perioperative sepsis in
the hypoalbuminemic group was 8.6%. Patients with metastatic
spinal tumors are predisposed to infection due to multiple risk
factors, including neutropenia, immunosuppression from onco-
logic therapies or corticosteroids, and compromise of epithelial
cell anatomic barriers from radiation therapy.56 In addition,
serum albumin is a negative acute phase reactant and low albu-
min concentrations may be a marker for subclinical illness.57-59
The presence of malnutrition in the setting of these risk factors
places patients with metastatic spinal tumors at high risk for
perioperative sepsis.
Hypoalbuminemia was also associated with a 4-fold and
nearly a 3-fold increased risk of prolonged hospitalization and
non-home discharge, respectively. These findings are consis-
tent with prior studies that have identified malnutrition as an
independent risk factor for prolonged hospitalization.19,60 Past
studies have reported an increase in LOS by 3 to 7 days for
any complication after surgical decompression of spinal
tumors.7,61 Prolonged hospitalization is associated with worse
perioperative outcomes, including an increased risk of
hospital-acquired conditions and higher overall hospital
costs.2,15,38 It is also a risk factor for non-home discharge,62
which occurred in approximately 60% of our hypoalbumine-
mic group. There appeared to be an albumin level–dependent
effect, with severe hypoalbuminemia being associated with a
2.5 times increased risk of prolonged hospitalization com-
pared to mild hypoalbuminemia.
Of note, we found that hypoalbuminemia was associated
with a lower rate of unplanned 30-day readmissions. This is
in contrast to prior studies that have demonstrated an increased
risk of readmission in patients with hypoalbuminemia.19
Patients with metastatic spinal tumors often have multiple med-
ical comorbidities and poor functional status at baseline, put-
ting them at high risk for perioperative mortality. The 30-day
mortality rate in our cohort was higher than previously
reported, possibly contributing to lower readmission rates.
Another contributing factor may have been related to the high
proportion of patients discharged to non-home facilities, which
likely include palliative care facilities where patients are typi-
cally not readmitted to acute care facilities.
The overall association between hypoalbuminemia and
perioperative mortality and morbidity following surgical
decompression of metastatic spinal tumors supports the imple-
mentation of strategies to optimize preoperative albumin levels
in this patient population. A proven method of addressing
hypoalbuminemia is nutritional supplementation, which has
been associated with lower perioperative complication rates
in various surgical subspecialties.63-65 Unfortunately, nutri-
tional supplementation in the form of total parenteral nutrition
(TPN) cannot easily reverse cachexia in cancer patients.66
Studies have demonstrated that severely malnourished patients
may require up to 10 to 14 days of preoperative TPN in order to
reduce postoperative complications.67,68 Furthermore, evi-
dence suggests a possible lack of benefit of TPN in patients
who are only mildly or moderately malnourished.68
There are several limitations to this study. First, the ACS-
NSQIP database categorizes patients according to CPT (Cur-
rent Procedural Terminology) codes, which do not provide
information about the location or histology of the primary
tumor. The nature of the primary tumor has a significant effect
on perioperative mortality and morbidity.37,42,69 Additionally,
the ACS-NSQIP database does not record the presence or
number of visceral metastases, which is another important
prognostic factor.70,71 In this study, we did not include other
markers that may be better correlated with nutritional status
than albumin. For instance, studies have suggested that pre-
albumin or transthyretin may be a more accurate marker of
nutritional status given its shorter half-life and increased sen-
sitivity to changes in protein level.72 Last, the ACS-NSQIP
Figure 3. Multivariate regression analysis of perioperative mortality
and complications that were significantly associated with varying
severities of hypoalbuminemia using mild hypoalbuminemia (ie, serum
albumin level of 3.3-3.4 g/dL) as the reference group. Adjusted odds
ratios are reported with 95% confidence intervals. Mild-moderate,
moderate-severe, and severe hypoalbuminemia were defined as a
serum albumin level of 3.1 to 3.2 g/dL, 2.8 to 3.0 g/dL, and 1.2 to 2.7 g/dL,
respectively. VTE, venous thromboembolism; LOS, length of stay.
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database is limited to only 30-day postoperative outcomes and
does not include long-term outcomes such as functional or
neurological status.
In conclusion, we examined the role of hypoalbuminemia as
an independent risk factor for 30-day perioperative mortality
and morbidity after surgical decompression of metastatic spinal
tumors. Hypoalbuminemia was a risk factor for perioperative
mortality, any complication, sepsis, intra- or postoperative
transfusion, prolonged hospitalization, and non-home dis-
charge. However, lower readmission rates were seen in patients
with hypoalbuminemia. There was also an albumin level–
dependent effect with worsening albumin depletion being asso-
ciated with higher rates of perioperative mortality and any
complication. These findings support optimization of nutri-
tional status in patients with metastatic spinal tumors prior to
surgical decompression.
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